Procoralan Union européenne - anglais - EMA (European Medicines Agency)

procoralan

les laboratoires servier - ivabradine hydrochloride - angina pectoris; heart failure - cardiac therapy - symptomatic treatment of chronic stable angina pectoris ivabradine is indicated for the symptomatic treatment of chronic stable angina pectoris in coronary artery disease adults with normal sinus rhythm and heart rate ≥ 70 bpm. ivabradine is indicated :in adults unable to tolerate or with a contraindication to the use of beta-blockersor in combination with beta-blockers in patients inadequately controlled with an optimal beta-blocker dose.treatment of chronic heart failure ivabradine is indicated in chronic heart failure nyha ii to iv class with systolic dysfunction, in patients in sinus rhythm and whose heart rate is ≥ 75 bpm, in combination with standard therapy including beta-blocker therapy or when beta-blocker therapy is contraindicated or not tolerated.

Rapiscan Union européenne - anglais - EMA (European Medicines Agency)

rapiscan

ge healthcare as  - regadenoson - myocardial perfusion imaging - cardiac therapy - this medicinal product is for diagnostic use only.rapiscan is a selective coronary vasodilator for use as a pharmacological stress agent for radionuclide myocardial perfusion imaging (mpi) in adult patients unable to undergo adequate exercise stress.

ENTERIC COATED ASPIRIN REGULAR STRENGTH- aspirin tablet, delayed release États-Unis - anglais - NLM (National Library of Medicine)

enteric coated aspirin regular strength- aspirin tablet, delayed release

mckesson corporation dba sky packaging - aspirin (unii: r16co5y76e) (aspirin - unii:r16co5y76e) - aspirin 325 mg in 325 - do not use - if you are allergic to aspirin or any other pain reliever/fever reducer stop use and ask a doctor if - you experience any of the following signs of stomach bleeding - feel faint have bloody or black stools vomit blood have stomach pain that does not get better - feel faint - have bloody or black stools - vomit blood - have stomach pain that does not get better - pain gets worse or lasts more than 10 days - fever gets worse or lasts more than 3 days - redness or swelling is present in the painful area - any new symptoms appear - ringing in the ears or a loss of hearing occurs use for the temporary relief of minor aches and pains due to: headache, colds, muscle pain, menstrual pain, toothache, minor pain of arthritis or as directed by your doctor pain reliever

Ranexa 500mg modified-release tablets Royaume-Uni - anglais - MHRA (Medicines & Healthcare Products Regulatory Agency)

ranexa 500mg modified-release tablets

a. menarini farmaceutica internazionale srl - ranolazine - modified-release tablet - 500mg

Ranexa 375mg modified-release tablets Royaume-Uni - anglais - MHRA (Medicines & Healthcare Products Regulatory Agency)

ranexa 375mg modified-release tablets

a. menarini farmaceutica internazionale srl - ranolazine - modified-release tablet - 375mg

Ranexa 750mg modified-release tablets Royaume-Uni - anglais - MHRA (Medicines & Healthcare Products Regulatory Agency)

ranexa 750mg modified-release tablets

a. menarini farmaceutica internazionale srl - ranolazine - modified-release tablet - 750mg